The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma

Published:2022-07-03 Issue:5 Volume:16 Page:1137-1149
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Chiang Nai-Jung,Hou Ya-Chin,Tan Kien Thiam,Tsai Hung-Wen,Lin Yih-Jyh,Yeh Yi-Chen,Chen Li-Tzong,Hou Ya-Fu,Chen Ming-Huang,Shan Yan-Shen

Funder

Ministry of Science and Technology, Taiwan

Health Promotion Administration, Ministry of Health and Welfare

National Health Research Institutes

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

https://link.springer.com/content/pdf/10.1007/s12072-022-10346-3.pdf

Reference27 articles.

1. Gupta A, Dixon E. Epidemiology and risk factors: intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr. 2017;6:101–104

2. Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: Epidemiology and risk factors. Liver Int. 2019;39:19–31

3. Shimada M. Highlights of topic “Intrahepatic cholangiocarcinoma: recent advancements in pathogenesis, diagnosis and treatment.” J Hepatobiliary Pancreat Sci. 2015;22:91–93

4. Anderson ARA, Weaver AM, Cummings PT, Quaranta V. Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell. 2006;127:905–915

5. Chan AW, Tong JH, Sung MY, Lai PB, To KF. Epstein-Barr virus-associated lymphoepithelioma-like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favourable outcome. Histopathology. 2014;65:674–683

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the clinicoradiological features and outcomes of lymphoepithelioma-like cholangiocarcinoma and conventional intrahepatic cholangiocarcinoma: A propensity score matching analysis;Journal of the Formosan Medical Association;2024-08

2. MiR-22-3p Inhibits 5-Fluorouracil Resistance in Cholangiocarcinoma Cells Through PTEN/PI3K/AKT Axis;ASSAY and Drug Development Technologies;2024-07-01

3. Unveiling the promise of PD1/PD-L1: A new dawn in immunotherapy for cholangiocarcinoma;Biomedicine & Pharmacotherapy;2024-06

4. MUC16: clinical targets with great potential;Clinical and Experimental Medicine;2024-05-17

5. Clinicopathological features of a rare cancer: Intrahepatic lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection;Clinics and Research in Hepatology and Gastroenterology;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3